Saskatoon, Saskatchewan — August 29, 2025 — Leads & Copy — MustGrow Biologics Corp. has announced the closing of a non-brokered private placement of 3,059,731 units at $0.70 per unit, raising approximately $2,141,812.
Each unit includes one common share and one common share purchase warrant, exercisable at $0.90 per share for 60 months. The company intends to use the proceeds for inventory production of its biofertility product TerraSanteTM, agricultural products for its distribution platform NexusBioAg, and for working capital.
Additionally, MustGrow has repriced 1,721,610 outstanding share purchase warrants from a previous private placement, lowering the exercise price to $0.90 per share. These warrants now include an acceleration clause. The company has also settled a shares for debt agreement, issuing approximately 3,407,134 shares at $0.70 per share to settle $2,385,000 in outstanding debt.
Certain insiders of the company participated in the LIFE Offering, the Warrant Repricing and Shares for Debenture Debt Settlement.
Corey Giasson, Director & CEO, can be reached at +1-306-668-2652 or info@mustgrow.ca.
Source: MustGrow Biologics Corp.
